Dense breasts, hormone levels are 2 separate, independent risk factors for breast cancer

August 20, 2007

The density of a woman’s breast tissue and her level of sex hormones are two strong and independent risk factors for breast cancer, according to a team of researchers from Harvard and Georgetown universities. The finding dispels the common belief that the risk associated with dense breasts merely reflects the same risk associated with high levels of circulating sex hormones, they say.

Their study, published in the August 1 issue of the Journal of the National Cancer Institute, found that the relative risk of developing breast cancer in post-menopausal woman with dense breasts was 400 percent higher than in women with fatty, non-dense breast tissue, and that high versus low levels of hormones (estrogen and testosterone) increased the relative risk by 200 percent. Adjusting for a woman’s circulating hormone levels did not reduce the risk associated with the level of breast density. Furthermore, these independent risk factors seemed to have additive effects so if a woman had both dense breasts and excess hormones, her risk was increased by 600 percent, the researchers found.

“We have found that dense breasts are not a marker for higher hormone levels, or vice versa, and this tells us each increases breast cancer risk via a different biochemical pathway,” said co-author Celia Byrne, Ph.D., an assistant professor in the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center. Byrne designed and conducted the study while she was an instructor of medicine at Harvard Medical School. The study’s three other authors, including the corresponding author, Rulla Tamini, Sc.D., were from Harvard.

Women at risk should pay attention to these early findings, even though they need to be confirmed and studied further, Byrne added. “Women who know they have dense breasts should make sure they have regular mammograms,” she said. Women usually don’t know if they have dense breast tissue and the best way to find out is through a digital mammogram, she explained. Additionally, post-menopausal women who are overweight can reduce their blood hormone levels by decreasing body fat, Byrne added, since fat itself is converted by the body to estrogen.

The findings represent an opportunity to both fine-tune existing breast cancer risk models, which, thanks to research by Byrne and her colleagues, now include breast density to help estimate a woman’s risk. But the model does not take into account hormone level, Byrne said. “If we could find out what causes breast tissue to be dense, and how that increases breast cancer risk, then we might have a new opportunity to help women lower their risk,” she said.

Byrne said she was surprised at the findings. “Our assumption was that this study would confirm what everyone had believed − that hormone levels explain breast density.” This presumption of an association between hormone levels and breast density was based on “the circumstantial evidence, such as the fact that during pregnancy, when hormones increase, breasts also grow in size,” she said. “But that is not what our study showed.”

In a 1995 study, Byrne and her colleagues discovered that women whose breasts contain at least 75 percent dense tissue are at a four- to six-fold greater risk of breast cancer than women with entirely fatty breasts (no measurable dense tissue). Recent research has suggested that having dense breast tissue may be partially an inherited genetic trait. Other recent studies have indicated that for women with dense breast digital mammography may be more effective for screening.

In this study of 773 postmenopausal women who participated in Harvard’s Nurses Health Study −253 who had breast cancer and 520 who didn’t − the researchers evaluated hormones in their blood and measured breast density using a computer-assisted analysis of mammograms. None of the women were using hormone replacement therapy (HRT) at the time they were evaluated.

There are several theories as to why dense breasts might increase a woman’s risk of developing breast cancer, Byrne said. One is that dense tissue has more epithelial cells than breasts that are not dense, and thus more possibilities exist that one or more of these cells will become cancerous. Another is that there is more “cross-talk” between the stromal cells in the breast, which produce a variety of hormones and growth factors, and epithelial cells in the tissue, which is where most breast cancer develops. The third is a combination of the first two theories, she said.

Much more work needs to be done to understand why breast density would increase breast cancer risk, the researchers wrote, and they noted that further studies should measure hormone levels directly within breast tissue, not indirectly through blood, as they chose to do in this first investigation.

Source: Georgetown University Medical Center

Explore further: Blood test can effectively rule out breast cancer, regardless of breast density

Related Stories

Blood test can effectively rule out breast cancer, regardless of breast density

October 26, 2017
A new study published in PLOS ONE demonstrates that Videssa Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense ...

Joan lunden's breast cancer journey: 'You feel so vulnerable'

October 26, 2017
(HealthDay)—Joan Lunden—co-host of "Good Morning America" for nearly two decades and a long-time health advocate—is now also a breast cancer survivor.

16 things experts wish you knew about breast cancer and screening

October 12, 2017
What these doctors say about breast cancer screening and treatment may surprise you.

Breast cancer screenings still best for early detection

October 12, 2017
(HealthDay)—Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says.

Intermountain healthcare researchers launch major three-year genomics breast cancer study

October 11, 2017
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a ...

Not all with dense breasts have high interval cancer risk

May 19, 2015
(HealthDay)—Not all women with high breast density have high risk of interval cancer, according to a study published in the May 19 issue of the Annals of Internal Medicine.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.